French Pharma Firm Transgene Utilizes Blockchain to Track Clinical Trials
In a recent press release, French biopharmaceutical firm Transgene announced its integration with blockchain supply chain traceability solution Hypertrust-X Chain for Clinical Trials for its individualized therapeutic vaccine against ovarian, head, and neck cancer to provide an immutable audit trail throughout the treatment process. In a bid to leverage the benefits of distributed ledger technology (DLT) to make its clinical trials process more transparent, Transgene has implemented Hypertrust Patient Data Care’s blockchain supply chain traceability product into its clinical trials project dubbed myvac.
Blockchain solves this by offering a decentralized source of data, thereby providing a high level of trust and transparency with regard to how data was collected and modified all along the supply chain. Hypertrust’s X-Chain platform securely stores all data gathered along the supply chain on a blockchain.
